Contrary to the notion that those who use cannabis may develop psychosis, its cannabinoid cannabidiol (CBD) may actually help treat psychosis instead. According to a new study published in The American Journal of Psychiatry, the daily use of CBD as an adjunctive therapy can help those who experience psychotic symptoms as a result of schizophrenia. The six-week randomized trial assessed the adjunctive use of 1000mg plant-derived CBD or placebo in 88 patients with schizophrenia daily. Those who received CBD had lower levels of psychotic symptoms and were more likely to have their clinicians report an improvement in wellness at the end of the trial. CBD also produced minor improvements in cognitive performance and overall functioning. Authors concluded, “These findings suggest that CBD has beneficial effects in patients with schizophrenia… As CBD’s effects do not appear to depend on dopamine receptor antagonism, this agent may represent a new class of treatment for the disorder.”
This information has been provided by NORML and approved by our Chief Medical Officer.